![Ashraf Amanullah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ashraf Amanullah
No open positions remaining
Profile
Ashraf Amanullah is currently Chief Technical Operations Officer & Executive VP at Inhibrx Biosciences, Inc. Formerly, Dr. Amanullah was Chief Technical Operations Officer & Executive VP at Sanofi AATD, Inc. from 2018 to 2024, Senior VP-Biologics Development & Manufacturing at aTyr Pharma, Inc. in 2018, Senior Director at Gilead Sciences, Inc. from 2011 to 2015, and Director-Process Development at Genentech, Inc. from 2006 to 2011.
Dr. Amanullah earned a doctorate from the University of Birmingham.
Ashraf Amanullah active positions
| Companies | Position | Start |
|---|
Former positions of Ashraf Amanullah
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Chief Tech/Sci/R&D Officer | 30/05/2024 |
| ATYR PHARMA, INC. | Corporate Officer/Principal | 01/07/2018 |
| GILEAD SCIENCES, INC. | Director/Board Member | 01/08/2015 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/08/2011 |
Training of Ashraf Amanullah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
aTyr Pharma, Inc.
 aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
- Stock Market
- Insiders
- Ashraf Amanullah
Choose MarketScreener 
